Abstract
loperamide hydrochloride is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. Its use in paediatric age group less than 12 years is not recommended. Toxicity with therapeutic dose has been reported to cause urinary retention, paralytic ileus, respiratory depression due to CNS depression in infants and toddlers.
Highlights
Loperamide (Imodium) is an anti diarrheal agent usually used in adults
We report a rare case of suspected loperamide toxicity in a neonate
The mainstay of treatment of acute diarrhea is rehydration therapy, antidiarrhoeals like loperamide may have a role for symptomatic relief with acute diarrhea but WHO does not recommend their use in children
Summary
Loperamide (Imodium) is an anti diarrheal agent usually used in adults. It is an opioid analogue which acts locally on the intestinal wall to decrease the gut motility and control the diarrhea [1]. Its passage of blood-brain barrier is minimal in therapeutic doses it is known to cause respiratory depression and paralytic ileus in younger children and infants [2]. There are a very few cases of loperamide toxicity in younger children reported so far never in a neonate [3, 4, 5]. We report a rare case of suspected loperamide toxicity in a neonate. Arterial blood gases was normal, respiratory acidosis was ruled out
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Pediatric Review: International Journal of Pediatric Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.